Quote | Lobe Sciences Ltd (OTCMKTS:LOBEF)
Last: | $0.0182 |
---|---|
Change Percent: | 17.03% |
Open: | $0.0151 |
Close: | $0.0182 |
High: | $0.0182 |
Low: | $0.0151 |
Volume: | 13,284 |
Last Trade Date Time: | 07/16/2024 03:00:00 am |
News | Lobe Sciences Ltd (OTCMKTS:LOBEF)
Company Exploring Alternative Value Creation Opportunities Convertible note for $500,000.00 USD, Short-term Debt Reduced and Balance Sheet Strengthened to Prepare the Company for Long Term Funding Strategy Annual General Meeting Set for 22 July 2024 Lobe Sciences Ltd. (O...
Accomplished Investor and Serial Entrepreneur Lobe Sciences Ltd. (OTCQB: LOBEF) (CSE: LOBE) ("Lobe" or the "Company"), a biopharmaceutical company focused on developing transformative medicines to treat rare diseases today announced that Wesley Ramjeet has agreed to join its Board of Di...
Message Board Posts | Lobe Sciences Ltd (OTCMKTS:LOBEF)
Subject | By | Source | When |
---|---|---|---|
$LOBEF Lobe Sciences Provides Update For 2023 Milestones https://finance.yahoo. | Mrogers23 | investorshub | 01/18/2023 2:02:50 PM |
$LOBEF $LOBE https://m.facebook.com/story.php?story_fbid=pfbid02C76XCRoPZmEQQaC | StarChild1 | investorshub | 01/17/2023 10:14:05 AM |
LOBEF LOBE SCIENCES LTD. LOBEF (OTCQB) LOBE.CN (CSE) Summary Stock Price: | Mrogers23 | investorshub | 01/16/2023 9:58:46 PM |
I got 8300 shares, hoping for big big | FlipFlopopotamus | investorshub | 08/18/2022 3:33:42 PM |
pennyMoMo: (CSE: $LOBE) (OTCQB: $LOBED)- Lobe Sciences Ltd. Announces Regulatory and Clinical Develo | pennyMoMo | investorshangout | 07/07/2022 5:39:20 PM |
News, Short Squeeze, Breakout and More Instantly...
Company Exploring Alternative Value Creation Opportunities Convertible note for $500,000.00 USD, Short-term Debt Reduced and Balance Sheet Strengthened to Prepare the Company for Long Term Funding Strategy Annual General Meeting Set for 22 July 2024 Lobe Sciences Ltd. (O...
Accomplished Investor and Serial Entrepreneur Lobe Sciences Ltd. (OTCQB: LOBEF) (CSE: LOBE) ("Lobe" or the "Company"), a biopharmaceutical company focused on developing transformative medicines to treat rare diseases today announced that Wesley Ramjeet has agreed to join its Board of Di...
Providing a Proven Track Record of Driving Growth and Innovation Lobe Sciences Ltd. (OTCQB: LOBEF) (CSE: LOBE) ("Lobe" or the "Company"), a biopharmaceutical company focused on developing transformative medicines to treat rare diseases today announced that Frederick D. Sancilio Ph.D. ha...